STO Equity Snapshot
SPRINT Weekly Equity Report
Sprint Bioscience AB (publ)
What the company does
Sprint Bioscience AB (publ), a pharmaceutical company, engages in the development of pharmaceutical products in the areas of cancer in Sweden. The company develops VPS34, a drug candidate for the treatment of various types of cancer by using immunotherapies; TREX1, a drug candidate for the treatment of immuno-oncology, radiotherapy and chemotherapy in the treatment of cancer. It also develops PETRA01, a drug candidate for the treatment of cancer. In addition, the company focuses on research of products for the treatment of tumor metabolism and nash. It has a research collaboration with the Experimental Drug Development …
What the weekly tape is saying
SPRINT closed the latest completed week at 3.68 SEK. The 4-week return is 1.7% and the 12-week return is 80.4%. Trend Signal is active, Market Dynamics is 0.55. Setup signature: Balanced read with a 63/100 composite read.
A compressed read of the whole setup
The radar blends trend persistence, momentum, Market Dynamics, Relative Strength, volume confirmation, and risk control into one weekly cockpit.
Scoreboard
16-week signal tape
Price, Trend Line, and Fair Value
Weekly price context with the latest close, trend position, Fair Value gap, drawdown, and 52-week range location.
52-week price path
Price map
- Trend Line
- 2.30 SEK
- Vs Trend Line
- 59.9%
- Fair Value
- 1.39 SEK
- Vs Fair Value
- 164.5%
- 52W High
- 4.21 SEK
- 52W Low
- 0.42 SEK
- Drawdown
- -12.6%
- Range Position
- 86.0%
Returns and trend persistence
Return windows separate the latest week from short-term and medium-term follow-through.
Return windows
Trend read
- Active Streak
- 35 weeks
- 52W Active Weeks
- 35
- 52W Active Breadth
- 67.3%
- Sector Scope
- SE Healthcare
- Sector Rank
- 22 of 158
- Sector Percentile
- 86.6%
Sector and industry pulse
Peer breadth helps separate a stock-specific move from a broader group rotation.
SE Healthcare
- Tracked Peers
- 100
- 4W Rank
- 38 of 100
- Avg 1W
- 2.8%
- Avg 4W
- 1.2%
- Trend Breadth
- 29.0%
- Positive MD
- 69.0%
SE Biotechnology
- Tracked Peers
- 59
- 4W Rank
- 19 of 59
- Avg 1W
- 3.1%
- Avg 4W
- -1.6%
- Trend Breadth
- 30.5%
- Positive RS
- 22.0%
Pressure, Relative Strength, and expectation
Market Dynamics and Relative Strength show whether buying pressure and relative leadership are confirming the price move.
Dynamics path
Signal state
- Market Dynamics
- 0.55
- 4W MD Change
- -49.4%
- Relative Strength
- 121.62
- 4W RS Change
- -23.1%
- Expectation
- Undecided
- Probability
- 45.58%
Participation and confirmation
Volume tells us whether the latest weekly move is being confirmed by unusual participation.
52-week volume profile
Volume map
- Latest Volume
- 2.5M
- 13W Average
- 3.5M
- 52W Average
- 2.4M
- Vs 13W
- 0.7x
- Vs 52W
- 1.0x
Volatility, downside weeks, and return shape
A compact risk profile shows whether the move is steady, volatile, or being driven by sharp one-week jumps.
26-week return distribution
Risk map
- 13W Volatility
- 15.8%
- 52W Volatility
- 21.1%
- Upside Weeks
- 29
- Downside Weeks
- 22
- Downside Breadth
- 42.3%
- Avg Gain / Loss
- 13.7% / -4.8%
Classification, opportunities, risks, and watch points
Top-level read across company classification, constructive evidence, caution points, and the next things that matter.
Classification
- Exchange
- STO
- Country
- SE
- Sector
- Healthcare
- Industry
- Biotechnology
- Currency
- SEK
- Market Cap
- 335.5M
Opportunity signals
- Trend Signal is active with a 35-week active streak.
- Price is above the Trend Line, keeping the weekly tape constructive.
- Price is above Fair Value, showing premium demand versus the model.
- Market Dynamics is positive on the latest completed week.
- Latest weekly return ranks in the strongest part of its sector group.
Risk signals
- No major top-level risk cluster is currently dominant.
Watch next
- Trend Line remains the key weekly regime level.
- Market Dynamics is the pressure gauge to monitor for confirmation or fade.
- A volume ratio above 1.5x would show stronger participation in the next move.
Recent completed weeks
The latest weekly rows behind the report snapshot.
| Week | Close | Return | Trend | Fair Value | MD | RS | Volume | Signal |
|---|---|---|---|---|---|---|---|---|
| 12 Jun 2026 | 3.68 SEK | 7.3% | 2.30 SEK | 1.39 SEK | 0.55 | 121.62 | 2.5M | On |
| 5 Jun 2026 | 3.43 SEK | -1.2% | 2.20 SEK | 1.37 SEK | 0.68 | 114.14 | 3.9M | On |
| 29 May 2026 | 3.47 SEK | 6.1% | 2.11 SEK | 1.35 SEK | 0.87 | 122.93 | 3.2M | On |
| 22 May 2026 | 3.27 SEK | -9.7% | 2.02 SEK | 1.33 SEK | 0.96 | 117.39 | 2.8M | On |
| 15 May 2026 | 3.62 SEK | -9.3% | 1.93 SEK | 1.32 SEK | 1.09 | 158.18 | 2.4M | On |
| 8 May 2026 | 3.99 SEK | 28.3% | 1.84 SEK | 1.30 SEK | 1.24 | 193.59 | 4.3M | On |
| 1 May 2026 | 3.11 SEK | 5.4% | 1.73 SEK | 1.28 SEK | 1.32 | 140.95 | 1.2M | On |
| 24 Apr 2026 | 2.95 SEK | -13.0% | 1.64 SEK | 1.26 SEK | 1.32 | 133.71 | 3.1M | On |
| 17 Apr 2026 | 3.39 SEK | -7.4% | 1.56 SEK | 1.25 SEK | 1.24 | 170.40 | 8.6M | On |
| 10 Apr 2026 | 3.66 SEK | 46.4% | 1.47 SEK | 1.23 SEK | 0.98 | 210.29 | 5.5M | On |
| 3 Apr 2026 | 2.50 SEK | 11.6% | 1.37 SEK | 1.21 SEK | 0.67 | 132.82 | 2.7M | On |
| 27 Mar 2026 | 2.24 SEK | 9.8% | 1.30 SEK | 1.20 SEK | 0.53 | 122.40 | 2.2M | On |
| 20 Mar 2026 | 2.04 SEK | 5.7% | 1.25 SEK | 1.19 SEK | 0.61 | 108.31 | 3.9M | On |
| 13 Mar 2026 | 1.93 SEK | 2.4% | 1.20 SEK | 1.18 SEK | 0.80 | 91.88 | 2.6M | On |